Amphotericin (Ambisome®)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £6M
- Sector
- HEALTH
- Published
- 26 Oct 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Gilead Sciences London
Description
Supply of Amphotericin (AmBisome®) to NHS Scotland. The Authority has awarded this Framework Agreement as a Single Supplier Framework per line.
Total Quantity or Scope
Supply of Amphotericin (AmBisome®)to NHS Scotland.
Award Detail
1 | Gilead Sciences (London)
|
Award Criteria
price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
Although the patent has expired on Ambisome® there is no known generic competition in the UK market place due to the difficulties in replicating the manufacturing process.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The total value in Sections II.1.7 and V.2.4 refers to the twenty four (24) months initial period and the total twenty four (24) months extension period. (SC Ref:669682)
Reference
- ocds-h6vhtk-02db24
- FTS 026738-2021